Stockreport

Seattle Genetics Reports Fourth Quarter and Full Year 2019 Financial Results

Seagen Inc.  (SGEN) 
Last seagen inc. earnings: 4/30 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.seattlegenetics.com
PDF -ADCETRIS® (Brentuximab Vedotin) Net Sales in U.S. and Canada of $627.7 Million in 2019, Including $166.2 Million in the Fourth Quarter--PADCEV™ (Enfortumab Vedotin-ejfv [Read more]